🩺 Clinical evidence, transparent mathematics, and a practical call to action. Lifestyle medicine, whole-person nursing, and sustained nurse coaching deserve serious implementation and evaluation. Nursing’s reach creates an opportunity to deliver effective care at scale; benefit depends on the intervention, patient population, access, and follow-through.
📅 Research brief • Evidence reviewed October 29, 2026 • Kitchen Monk™ and Flourishing Nursing™. This is a focused evidence summary of the research discussed here, not an exhaustive systematic review or original clinical study. Every source is linked so readers can inspect the findings. Labels used below: 🔬 Observed in a study · 🧭 Proposed framework · 🧮 Hypothetical scenario.
💚 What this means for you and your family
- 🥗 Small, steady changes can help. In a large study of adults at high risk, a structured program of healthier eating and regular activity cut new cases of type 2 diabetes roughly in half over about three years, and the benefit was still there, though smaller, 15 years later.
- 📞 Support from a nurse can help too. In some studies, regular phone coaching from nurses modestly improved blood sugar or people’s confidence in managing diabetes. In another, it didn’t, and many people got fewer calls than planned. How often you get support, and whether it fits your life, matters.
- 💊 Keep your clinician in the loop. If you take medicine for diabetes or blood pressure, changing how you eat or move can change what you need. Check your blood sugar or blood pressure as advised, and let the person who prescribes your medicine make any changes.
- 🌱 No blame here. Illness is not a personal failure. Cost, time, transportation, and stress all shape what’s possible, and good care helps with those too.
🩺 The evidence at a glance
| Question | What the evidence shows |
|---|---|
| Can intensive lifestyle care prevent or delay diabetes? | 🔬 Yes. The Diabetes Prevention Program showed fewer new diagnoses in high-risk adults, with a smaller but lasting difference at 15 years. [1–2] |
| Can nurse coaching improve diabetes care? | 🔬 Some randomized trials show modestly better glucose control or self-efficacy; a pragmatic trial found no added glucose benefit. Effects in reviews are modest and vary widely. Delivery matters. [3–5, 7–9] |
| Does improved weight or hemoglobin A1c automatically prove fewer heart attacks? | 🔬 No. Look AHEAD improved several risk factors without significantly reducing its primary cardiovascular-event outcome. [6] |
| Has nationwide adoption of this exact combined model been proven? | 🧭 No. The studies below do not test universal adoption of lifestyle medicine + holistic nursing + nurse coaching. National totals below are 🧮 scenarios, not measured outcomes. |
🔬 1. Diabetes prevention: what the landmark trial actually found
The Diabetes Prevention Program randomized 3,234 high-risk adults (average follow-up 2.8 years). Lifestyle treatment targeted at least 7% weight loss and at least 150 minutes of activity weekly. Estimated three-year cumulative diabetes incidence, from the article’s results, was 28.9% with placebo versus 14.4% with intensive lifestyle intervention. The absolute difference was 14.5 percentage points: about 145 fewer diagnoses per 1,000 similar participants, with a number needed to treat of about seven (reported as 6.9) over three years. [1]
The trial reported a 58% reduction in incidence over its follow-up. That relative incidence reduction and the 14.5-percentage-point difference in estimated three-year cumulative risk are different statistical measures. Neither means 58 of every 100 people avoid diabetes. In long-term follow-up (the Diabetes Prevention Program Outcomes Study), the lifestyle group’s incidence was still 27% lower at 15 years, a smaller effect than in the original trial. [1–2]
| Comparable high-risk participants | 🧮 Illustrative fewer diagnoses over three years at the trial’s 14.5-point absolute difference |
|---|---|
| 1,000 | 145 |
| 10,000 | 1,450 |
| 100,000 | 14,500 |
| 1,000,000 | 145,000 |
Interpretation: these are extrapolations assuming comparable risk, care, and effectiveness. The intervention was intensive; a brief conversation or recipe handout is not equivalent. It was not specifically a salt-, oil-, and sugar-free, exclusively plant-based, or nurse-coaching trial. These findings cannot validate every element of our preferred model. Prevented or delayed during follow-up does not mean permanently prevented.
📞 2. Direct evidence for nurse coaching: benefits and a null result
| 🔬 Randomized study | Result | Clinical meaning and limit |
|---|---|---|
| Nurse-led telecoaching in primary care, Belgium, 574 randomized [3] | At six months, hemoglobin A1c was 0.2 percentage points lower overall than usual care (95% confidence interval 0.1 to 0.3), and 0.4 points lower in the subgroup starting at 7% or higher. Similar differences were reported at 18 months. | Supports a modest average glycemic benefit in a fairly well-controlled population (average starting hemoglobin A1c about 7%); it does not prove remission or fewer cardiovascular events. |
| Nurse telehealth coaching at six rural community health centers, California, 121 randomized and 101 analyzed [4] | Five coaching sessions using motivational interviewing improved diabetes self-efficacy (empowerment score) at nine months compared with usual care. | Confidence in self-management matters. Hemoglobin A1c was not measured, so this trial says nothing about glucose control, admissions, or survival. |
| Patient Engagement and Coaching for Health trial (known as PEACH), Australia, 473 patients in 59 randomized practices [5] | No significant hemoglobin A1c difference at 18 months: adjusted difference 0.02 percentage points, 95% confidence interval −0.20 to 0.24. A quarter of intervention patients received no coaching; the median was 3 sessions, against 9 planned contacts. | The trial does not show why benefit was absent. Lower-than-planned delivery means training, protected time, engagement, and clinical coordination all need to be measured, not assumed. |
Systematic reviews point the same way: benefits are real but modest, and they vary widely between studies. A 2019 review of 12 randomized trials (3,030 participants) reported improvements in glucose control and systolic blood pressure with nurse-led telecoaching; its pooled glucose figure is not quoted here because the abstract does not state its units. [7] A 2024 review of 35 randomized trials of nurse-led hypertension care in primary care found long-term systolic blood pressure about 2.3 millimeters of mercury lower, but the effect was not significant when only trials at low risk of bias were counted. [8] A 2025 review of 13 trials of nurse-led telephone support (2,294 participants) found hemoglobin A1c about 0.6 percentage points lower, with very high variation between trials. [9] Reviews and the trials inside them are not separate patient populations, so their results are never added together.
⚖️ 3. The important limit: risk factors and major events are different outcomes
🔬 Look AHEAD randomized 5,145 adults with type 2 diabetes and overweight or obesity. Intensive lifestyle treatment improved weight, fitness, and hemoglobin A1c, but after a median 9.6 years did not significantly reduce the primary composite cardiovascular outcome: hazard ratio 0.95, 95% confidence interval 0.83–1.09. The trial was stopped early because further benefit on that outcome was unlikely. [6]
Our research standard is to measure the outcome we claim. Improved glucose control can be valuable without proving a reduction in heart attacks, strokes, admissions, or mortality. We do not calculate lives saved or financial savings from workforce size alone.
👩🏽⚕️ 4. From 5.94 million workforce jobs to potential patient reach
The seven workforce figures sum to 5,937,800 jobs. On October 29, 2026 we checked six of them (registered nurses, licensed practical and vocational nurses, nurse practitioners, nurse anesthetists, nurse-midwives, and postsecondary nursing instructors) against the Bureau of Labor Statistics May 2025 release published May 15, 2026; the nursing assistant figure (1,448,910) matches published summaries of the same May 2025 survey. These are counts of jobs, not people: one person may hold more than one job, and self-employed workers are not included. Nursing assistants contribute to the nursing care team but are not licensed nurses. Role, setting, workload, and scope affect how each member contributes.
| 🧮 Participation assumption | Workforce jobs represented | Potential annual reach at 10 distinct patients per participating role |
|---|---|---|
| 1% | 59,378 | 593,780 |
| 10% | 593,780 | 5,937,800 |
| 25% | 1,484,450 | 14,844,500 |
| 50% | 2,968,900 | 29,689,000 |
| 100% | 5,937,800 | 59,378,000 |
These are capacity illustrations. They assume 10 distinct eligible patients per role per year, with duplication removed across professionals. They are not observed enrollment, staffing recommendations, or guaranteed outcomes. The same patient seen by five team members counts once.
🧮 5. A transparent national outcome scenario
Formula: unique eligible patients entering care × engagement fraction × assumed absolute benefit among engaged patients = illustrative additional patients benefiting.
Example: 5,937,800 workforce jobs × 10% participation × 10 unique eligible patients = 5,937,800 entrants in one annual enrollment cohort. Assume 50% sufficiently engage: 2,968,900. Assume a five-percentage-point absolute reduction in three-year diabetes risk among those engaged, with zero additional benefit among others: 2,968,900 × 0.05 = 148,445 fewer diagnoses over three years for that cohort.
All scenario assumptions are hypothetical. The 50% engagement and five-point absolute benefit are not estimates established by the cited trials. If benefit were two points, the same scenario yields 59,378; at ten points, 296,890. These are sensitivity examples, not confidence intervals, predictions, or demonstrated national outcomes. Do not multiply annual enrollment by years without addressing repeat patients and overlapping follow-up.
For actual evaluation, compare all enrolled patients with appropriate usual-care controls and report intention-to-treat results, attrition, and missing data. If the chosen benefit estimate already includes dropout, do not discount it for engagement again.
🧭 6. What the combined model should deliver (proposed framework)
| Component | Practical role | Outcome to assess |
|---|---|---|
| 🥦 Lifestyle medicine | Individualized nutrition, movement, sleep, stress, relationships, and substance-use support. | Blood pressure, hemoglobin A1c, tobacco cessation, activity, sleep, disease incidence. |
| 🌿 Holistic nursing | Assess symptoms, culture, emotional health, meaning, patient-requested spiritual support, family, and practical barriers. | Function, symptom burden, validated quality of life, unmet needs, patient experience. |
| 🧭 Nurse coaching | Patient-selected goals, motivational interviewing, problem-solving, continuing support, and referral. | Goal attainment, self-efficacy, retention, sustained behaviors. |
| 🩺 Coordinated treatment | Assessment, medication review, referrals, and monitoring within professional scope. | Adverse events, appropriate medication use, continuity, clinical outcomes. |
This table is a proposed implementation framework. The cited studies do not isolate the added effect of holistic nursing or prove that combining the components produces additive benefits; we found no trial that tests that question directly. Coaching should respect patient preferences and resources; illness is not evidence of personal failure.
Assistants can reinforce meals, mobility, routines, dignity, and reporting concerns. Licensed nurses can assess, educate, coordinate, and coach within scope and competence. Appropriately authorized prescribers manage diagnosis and medication changes. Educators and leaders build training, protected time, supervision, and evaluation. Universal participation means coordinated contributions and access to trained coaches, not identical duties or a nurse-coach credential for everyone.
Support access to affordable food, safe movement, interpreters, transportation, disability accommodations, and alternatives to digital participation. Monitor glucose and blood pressure when substantial changes are made; medication adjustments require the responsible clinician. Coaching complements necessary medical treatment.
📋 7. The patient-outcome scorecard
| Domain | What to report |
|---|---|
| 🩸 Clinical outcomes | Standardized blood pressure and hemoglobin A1c, incident diabetes, lipids where relevant, tobacco cessation, and appropriately defined remission where relevant. |
| 🚶 Everyday life | Function, pain or symptom burden, sleep, validated quality of life, self-efficacy, and patient-selected goals. |
| 🛡️ Safety and treatment | Low blood sugar, symptomatic low blood pressure, other adverse events, medication appropriateness and burden, and coordination with the responsible prescriber. |
| 🏥 Major outcomes | Emergency visits, hospitalizations, cardiovascular events, mortality—measured directly with adequate follow-up. |
| ⚖️ Delivery and equity | Enrollment, sessions delivered, retention, access barriers, missing data, resources used, and outcomes by relevant population groups. |
Report baseline risk, sample size, comparator, follow-up duration, effect sizes, confidence intervals, and harms. Avoid adding overlapping outcomes or treating improved biomarkers as a count of people cured. Reflection tools such as the Garden Soil Assessment™ and Cup of Flourishing™ support engagement; they are not validated clinical instruments.
🗂️ Evidence table: study by study
Each entry lists what the study was, who took part, what was compared, what it found and its limits. 🔬 = randomized trial or review of trials; 🏛️ = organizational report or case study. Fields not reported in the sources we checked are left out rather than guessed. Reviews and the trials inside them are never added together.
🔬 [1] Diabetes Prevention Program, 2002
- Design: Multicenter randomized trial; placebo-controlled for the metformin arm
- Population and setting: 3,234 adults with raised glucose but no diabetes (mean age 51, mean body mass index 34); 27 United States centers
- Intervention and comparator: Intensive lifestyle program (at least 7% weight loss and 150 minutes of activity a week) or metformin, versus placebo
- Duration: Mean follow-up 2.8 years
- Outcome: New type 2 diabetes
- Effect: Lifestyle: 4.8 versus 11.0 cases per 100 person-years; 58% lower incidence (95% confidence interval 48% to 66%)
- Absolute effect: Estimated three-year cumulative incidence 14.4% versus 28.9%: 14.5 percentage points; number needed to treat about 6.9 over three years
- Harms: Not summarized in the abstract
- Limits: High-risk volunteers; glucose-defined endpoint, not complications; not a test of nurse coaching or a diet free of added salt, oil and sugar
- Funding: United States government (National Institutes of Health)
- Applicability: Supports intensive lifestyle programs for prevention; does not validate our full model
- 🔗 Read the source
🔬 [2] Diabetes Prevention Program long-term follow-up
- Design: Government summary of the trial and its long-term outcomes study (2,776 of 3,149 surviving participants)
- Effect: Lifestyle group’s diabetes incidence 34% lower at 10 years and 27% lower at 15 years
- Limits: Effect shrinks over time; observational follow-up after the trial ended
- Overlap: Same participants as [1]; never added to [1]
- 🔗 Read the source
🔬 [3] Nurse-led telecoaching, Belgium, 2016
- Design: Randomized trial in primary care
- Population: 574 people with type 2 diabetes on glucose-lowering medicine (287 per group); average starting hemoglobin A1c about 7.0%
- Intervention and comparator: Nurse-led telephone coaching versus usual care
- Duration: Primary outcome at 6 months; follow-up to 18 months
- Effect: Hemoglobin A1c 0.2 percentage points lower at 6 months (95% confidence interval 0.1 to 0.3); 0.4 lower in those starting at 7% or higher; similar at 18 months
- Harms: Not reported in the abstract
- Funding: European Regional Development Fund and Flemish Government, with grants from insurers and companies; funders had no role
- Applicability: Small average benefit in a fairly well-controlled population
- 🔗 Read the source
🔬 [4] Nurse telehealth coaching, rural California, 2014
- Design: Randomized trial; 121 randomized, 101 analyzed
- Intervention and comparator: Five motivational-interviewing coaching sessions versus usual care
- Duration: 9 months
- Effect: Higher diabetes self-efficacy (empowerment score 4.03 versus 3.64)
- Limits: Hemoglobin A1c not measured; small; self-reported outcome
- Funding: National Institutes of Health
- 🔗 Read the source
🔬 [5] Patient Engagement and Coaching for Health trial, Australia, 2013
- Design: Pragmatic cluster randomized trial: 59 general practices, 473 patients
- Population: Type 2 diabetes with hemoglobin A1c above 7.5% in the past year
- Intervention and comparator: Practice-nurse telephone coaching (planned 8 calls and 1 visit) versus usual care
- Duration: 18 months
- Effect: No difference: hemoglobin A1c 0.02 percentage points (95% confidence interval −0.20 to 0.24)
- Delivery: Median 3 sessions received; a quarter received none
- Funding: Australian National Health and Medical Research Council; funder had no role
- Finding type: Null result, kept visible
- 🔗 Read the source
🔬 [6] Look AHEAD, 2013
- Design: Randomized trial at 16 United States centers
- Population: 5,145 adults with type 2 diabetes and overweight or obesity
- Intervention and comparator: Intensive lifestyle program versus diabetes support and education
- Duration: Median 9.6 years; stopped early after a futility analysis
- Outcome: Cardiovascular death, heart attack, stroke or hospitalization for angina
- Effect: Hazard ratio 0.95 (95% confidence interval 0.83 to 1.09): no significant reduction
- Applicability: Improved risk factors did not translate into fewer major events
- 🔗 Read the source
🔬 [7] Review of nurse-led telecoaching, 2019
- Design: Systematic review and meta-analysis of 12 randomized trials (3,030 participants)
- Effect: Systolic blood pressure about 2.2 millimeters of mercury lower; a pooled glucose result whose units are not stated in the abstract, so it is not quoted
- Overlap: Likely includes [3], [4] and [5]; never added to them
- 🔗 Read the source
🔬 [8] Review of nurse-led hypertension care, 2024
- Design: Systematic review and meta-analysis of 35 randomized trials in primary care
- Effect: Long-term systolic blood pressure about 2.3 millimeters of mercury lower; not significant when only trials at low risk of bias were counted
- 🔗 Read the source
🔬 [9] Review of nurse-led telephone support for type 2 diabetes, 2025
- Design: Systematic review and meta-analysis of 13 trials (2,294 participants)
- Effect: Hemoglobin A1c about 0.6 percentage points lower, with very high variation between trials
- Overlap: May share trials with [7]; never added together
- 🔗 Read the source
🔬 [10] Transitional care for older adults with heart failure, 2004
- Design: Randomized trial in six Philadelphia hospitals
- Population: 239 adults aged 65 and older admitted from home with heart failure (118 intervention, 121 control)
- Intervention: Three months of advanced-practice-nurse transitional care: hospital visits, at least eight home visits, telephone access seven days a week
- Comparator: Usual discharge planning and home care
- Outcome: Time to first readmission or death; total all-cause readmissions over 52 weeks
- Effect: 104 versus 162 total readmissions (events); mean total cost $7,636 versus $12,481 per person; readmission or death 47.5% versus 61.2%
- Not significant: Share readmitted at least once, 44.9% versus 55.4%; heart-failure-specific readmissions
- Limits: About 31% attrition; one city; costs exclude medicines; benefit faded after six months
- Funding: National Institute of Nursing Research
- Applicability: Supports nurse-led transitional care for similar patients; not a test of lifestyle medicine or coaching
- 🔗 Read the source
🔬 [11] Discharge planning and home follow-up for older adults, 1999
- Design: Randomized trial in two Philadelphia hospitals
- Population: 363 adults aged 65 and older with selected medical and surgical conditions
- Intervention: Advanced-practice-nurse discharge planning and home follow-up for 4 weeks after discharge
- Outcome window: 24 weeks; all-cause readmissions at any hospital
- Effect: Readmitted at least once: 20.3% versus 37.1% (16.8 percentage points fewer)
- Limits: About 28% attrition; two sites; reimbursements rather than costs
- Funding: National Institute of Nursing Research
- 🔗 Read the source
🏛️ [12] Buurtzorg case study and Dutch government-commissioned analysis, 2015
- Design: Organizational case study (Commonwealth Fund) reporting a consultancy analysis commissioned by the Dutch Ministry of Health (KPMG, January 2015)
- Effect: 108 versus 168 home-care hours per client per year; home-care cost per client about €6,428 versus €7,995; total cost including follow-on care about €15,357 versus €15,856
- Limits: Not randomized; case-mix adjustment unclear; follow-on costs were higher; the government letter notes statistical limits
- Source letter: Dutch parliamentary letter, January 22, 2015
- 🔗 Read the source
🏛️ [13] Adapted Buurtzorg team in England, 2018
- Design: Mixed-methods case study at one inner-London site
- Effect: Feasible and acceptable; valued continuity; more attractive work for nurses
- Limits: No clinical outcomes, costs or readmissions compared with standard care
- 🔗 Read the source
🏛️ [14] Buurtzorg-derived models outside the Netherlands, 2022
- Design: Scoping review of 25 publications, without quality appraisal
- Effect: Person-centered care and high satisfaction; inconclusive cost evidence; one controlled Finnish study found no cost benefit at one year
- Overlap: Includes [13]
- 🔗 Read the source
📚 Research references: read the original findings
[1] Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine 2002;346(6):393–403. Digital Object Identifier 10.1056/NEJMoa012512. Original randomized trial.
[2] National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program: design, initial results, and long-term follow-up.
[3] Odnoletkova I, et al. Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching. Diabetic Medicine 2016;33(6):777–785. Randomized trial (Digital Object Identifier 10.1111/dme.13092).
[4] Young H, Miyamoto S, Ward D, Dharmar M, Tang-Feldman Y, Berglund L. Sustained effects of a nurse coaching intervention via telehealth to improve health behavior change in diabetes. Telemedicine and e-Health 2014;20(9):828–834. Randomized trial (Digital Object Identifier 10.1089/tmj.2013.0326).
[5] Blackberry ID, et al. Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement and Coaching for Health (PEACH) pragmatic cluster randomised controlled trial. British Medical Journal 2013;347:f5272. Cluster randomized trial (Digital Object Identifier 10.1136/bmj.f5272).
[6] Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England Journal of Medicine 2013;369(2):145–154. Randomized trial (Digital Object Identifier 10.1056/NEJMoa1212914).
[7] Chen DY, Wu XV, Chan EY, Goh YS. Nurse-Led Tele-Coaching on Modifiable Cardiovascular Risk Factors in People with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Worldviews on Evidence-Based Nursing 2019;16(6):424–432. Systematic review (Digital Object Identifier 10.1111/wvn.12409).
[8] Ito M, et al. Nurse-led interventions for hypertension in primary care: systematic review and meta-analysis. BMC Primary Care 2024;25:143. Systematic review (Digital Object Identifier 10.1186/s12875-024-02380-x).
[9] Chen Y, et al. Nurse-led telephone interventions for type 2 diabetes: systematic review and meta-analysis. BMC Nursing 2025;24:284. Systematic review (Digital Object Identifier 10.1186/s12912-025-02782-x).
[10] Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. Journal of the American Geriatrics Society 2004;52(5):675–684. Randomized trial (PubMed 15086645).
[11] Naylor MD, Brooten D, Campbell R, et al. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. Journal of the American Medical Association 1999;281(7):613–620. Randomized trial (Digital Object Identifier 10.1001/jama.281.7.613).
[12] Gray BH, Sarnak DO, Burgers JS. Home Care by Self-Governing Nursing Teams: The Netherlands’ Buurtzorg Model. Commonwealth Fund, May 2015. Case study; Dutch parliamentary letter on the KPMG analysis (2015).
[13] Drennan VM, Calestani M, Ross F, Saunders M, West P. Tackling the workforce crisis in district nursing: can the Dutch Buurtzorg model offer a solution and a better patient experience? BMJ Open 2018;8:e021931. Case study (Digital Object Identifier 10.1136/bmjopen-2018-021931).
[14] Hegedüs A, Schürch A, Bischofberger I. Implementing Buurtzorg-derived models in the home care setting: a scoping review. International Journal of Nursing Studies Advances 2022;4:100061. Scoping review (Digital Object Identifier 10.1016/j.ijnsa.2022.100061).
Denominator source: Healthcare Cost and Utilization Project, Statistical Brief 316 (2022 data, posted February 2026). Brief. Workforce source: Bureau of Labor Statistics, Occupational Employment and Wages, May 2025 (released May 15, 2026). News release.
🌱 Our call to action
Equip nursing teams to deliver evidence-based lifestyle support, whole-person care, and sustained coaching—and measure whether patients live better. Workforce reach makes scale possible. Accessible care, competent delivery, and demonstrated patient benefit make it worthwhile.
📝 Change log
- October 28, 2026: brief published.
- October 29, 2026: all seven original references checked against publisher records; corrected the rural telehealth trial (121 randomized, 101 analyzed; hemoglobin A1c not measured) [4]; added trial details for the Belgian, Patient Engagement and Coaching for Health, and Look AHEAD trials [3, 5, 6]; added Diabetes Prevention Program 15-year follow-up [2]; added two newer systematic reviews [8–9]; confirmed the workforce total against the Bureau of Labor Statistics May 2025 release; added a plain-language summary for families, evidence labels, and jump buttons; spelled out abbreviations.
- October 29, 2026 (later): added a study-by-study evidence table [1–14]; added five sources on nurse-led transitional care and neighborhood nursing teams [10–14].
- October 29, 2026 (evening): removed the section on a draft national readmission projection pending review.
Educational information, not medical advice.
